In the News

Share
1717 News Items found
Richard J. O'Reilly, MD
A True Giant in Cancer Care: Memorial Sloan Kettering Cancer Center’s Richard J. O’Reilly, MD, Inducted into the 2021 Giants of Cancer Care®
Memorial Sloan Kettering Cancer Center (MSK) is proud to announce that Richard J. O’Reilly, MD, was named to the Ninth Annual Giants of Cancer Care®.
In the Lab
Geneticist Michael Berger
How Do Inherited Gene Mutations Cause Cancer? A New Database Will Help Researchers Find Out
In a new paper, a collaborative team of MSK experts reports how a novel tool will help researchers learn more about the role of inherited hereditary mutations.
Pamela R. Drullinsky
MSK Breast Cancer Expert Shares Tips for Women with Telemundo Audience
MSK’s Pamela Drullinsky, MD, a breast medical oncologist and Regional Care Network Medical Site Director of MSK Nassau, joined one of her patients on a recent segment on Noticiero Telemundo 47 for breast cancer awareness month.
Feature
Jianjiong Gao, Hongxin Zhang, Nikolaus Schultz, Debyani Chakravarty, and Sarah Suehnholz stand together on a terrace
A Milestone for Precision Oncology: FDA Gives Green Light to MSK’s Genetic Database
OncoKB, a database developed and maintained by investigators at MSK, helps match patients with targeted therapies based on the mutations found in their tumors.
Memorial Sloan Kettering researchers Luc Morris and Nils Weinhold
Machine Learning Approach Takes MSK Researchers Beyond Known Method to Predict Immunotherapy Response
Learn about recent research led by MSK physician-scientist Luc Morris, who is trying to better predict who will benefit from immunotherapy.
Man in surgical scrubs looks at reader
True Grit: One Man’s Incredible Journey To Become a Doctor at MSK
Learn how one man's determination to be a doctor took him on an incredible journey from working at a car wash in the Bronx to becoming a physician at Memorial Sloan Kettering Cancer Center, with the help of mentors and a world-class work ethic.
Scientists Learn More about How Lung Cancer Becomes Resistant to Drugs
By switching from one cellular identity to another, lung cancer cells can evade targeted therapies. MSK scientists are trying to stop that from happening.
Memorial Sloan Kettering Cancer Center named to Fast Company's “Brands That Matter” list.
Memorial Sloan Kettering Cancer Center Named in Fast Company’s First Annual List of “Brands That Matter”
Memorial Sloan Kettering Cancer Center (MSK) is proud to announce it has been named to the “Brands that Matter” list by Fast Company.
Memorial Sloan Kettering thoracic surgeon Prasad Adusumilli
New Finding Could Predict Which People with Lung Cancer Will Benefit from Chemotherapy
Researchers identify a biomarker that could predict which lung cancer patients will respond to chemotherapy.